Reven Pharmaceuticals

About:

Reven Pharmaceuticals is a clinical-stage company providing solutions for the treatment of vascular and metabolic-related conditions.

Website: http://reven.com

Twitter/X: revenpharma

Description:

Reven Pharmaceuticals is a clinical-stage company providing solutions for the treatment of vascular and metabolic-related conditions. Its services offer products such as critical limb ischemia, peripheral arterial disease, coronary artery disease, and endothelial dysfunction that enable patients to get advanced products for their diseases and recover faster. It was founded in 1999 and headquartered in Golden, Colorado.

Total Funding Amount:

$67.3M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Golden, Colorado, United States

Founded Date:

1999-01-01

Contact Email:

peter.lange(AT)reven.com

Founders:

Brian Denomme, Peter Lange

Number of Employees:

1-10

Last Funding Date:

2019-01-01

IPO Status:

Private

Industries:

© 2025 bioDAO.ai